IT is a fact that blood pressure is the single most important risk factor for stroke. Seventy-five percent of all strokes are caused by high blood pressure. A recent National Health and Morbidity Survey showed that 46% of those aged 30 and above suffer from high blood pressure. Even worse, 64% are unaware of their condition and are like walking time bombs.
How is blood pressure related to stroke?
High blood pressure over the long term can weaken and damage the inner blood vessel wall. Fatty deposits such as cholesterol stick to these damaged parts easily and can eventually form plaques, which cause narrowing of the blood vessel and sometimes, complete blockage. If the blockage occurs inside the brain, this can cause stroke. Sometimes, these plaques can break off and move inside the blood vessel, eventually lodging in a smaller artery in the brain – another cause of stroke.
Get early tocotrienol protection
If you have high blood pressure, reducing your risk for stroke through appropriate medications and a healthy lifestyle is important. You can also protect your brain cells with a neuroprotective agent. Palm tocotrienols are well researched for its neuroprotective functions.
Recent breakthrough research shows palm tocotrienols are able to prevent brain cells from dying and can also help improve blood flow to the affected area during stroke. This helps minimise brain cell death in the event of a stroke. Every brain cell that can be salvaged may make a huge difference in terms of survival and quality of life. It is important to have sufficient levels of palm tocotrienols in the brain cells before stroke occurs.
Patients with high blood pressure benefit from having such protection. This is especially because blood pressure levels can vary even with proper medication due to effects of emotion, stress, diet and such. Any patient at medium- to high-risk for stroke also needs such protection before it is too late. This includes patients with multiple risk factors. Patients who have had mini-strokes or strokes are at an even higher risk and need protection as soon as possible. Recent research conducted in Ohio State University in the United States showed taking 200mg of palm tocotrienols twice a day is able to minimise the extent of brain damage in the event of a stroke. This significant result led to various other studies, which all displayed the same trend. Researchers at Universiti Sains Malaysia (USM) also recently concluded a study in humans that further supports the neuroprotective effects of tocotrienols.
Absorption of a compound consumed should be an imperative component when deciding on a suitable supplement. Inadequate absorption leads to ineffective treatment/prevention, and can be a waste of resource.
Palm tocotrienols by nature is known to be poorly absorbed into the human body. A self-emulsifying system has been shown to be effective in increasing the absorption of palm tocotrienols by 300%. This system has also been used in published research that further solidifies the absorption and distribution of palm tocotrienols. Prof Chandan Sen from the Ohio State University proved that taking 200mg of palm tocotrienols formulated with a selfemulsifying system twice daily is able to reach vital human organs, including the brain.
To learn more about your stroke risk, log on to www.hovid.com/stroke or call 1800 882 228 to request for a free self-scoring stroke risk card produced in collaboration with the National Stroke Association of Malaysia (NASAM).
This article is contributed by Hovid, a leading pharmaceutical manufacturer globally, and a pioneer in palm tocotrienol global research.